h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
NIHTVBi012-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
NIHTVBi012-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
NIHTVBi012-A (RRID:CVCL_YM84)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
15th June 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
External Databases
Cellosaurus
CVCL_YM84
Wikidata
Q98127888
General Information
Publications
Jin H et al. Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation. Stem cell research. 2019 Dec;41:101586.
Ponsford MJ et al. Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE Syndrome. Frontiers in pediatrics. 2020;8:575.
Dmitrieva NI et al. Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome. The Journal of clinical investigation. 2020 Aug 3;130(8):4167-4181.
Yu Z et al. STAT3 modulates reprogramming efficiency of human somatic cells; insights from autosomal dominant Hyper IgE syndrome caused by STAT3 mutations. Biology open. 2020 Sep 10;9(9).
Harper RL et al. Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases. Seminars in immunopathology. 2022 May;44(3):259-268.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.